[{"id":"a0325957-4da9-40a5-b181-00dd056940d7","acronym":"","url":"https://clinicaltrials.gov/study/NCT02350673","created_at":"2021-01-18T11:10:56.487Z","updated_at":"2024-07-02T16:36:51.298Z","phase":"Phase 1b","brief_title":"A Study of Intravenous (IV) Cergutuzumab Amunaleukin and Atezolizumab in Combination in Participants With Locally Advanced and/or Metastatic Solid Tumors","source_id_and_acronym":"NCT02350673","lead_sponsor":"Hoffmann-La Roche","biomarkers":" CD8 • CEACAM5","pipe":" | ","alterations":" CEACAM5 expression","tags":["CD8 • CEACAM5"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CEACAM5 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Tecentriq (atezolizumab) • cergutuzumab amunaleukin (RG7813)"],"overall_status":"Completed","enrollment":" Enrollment 70","initiation":"Initiation: 06/29/2015","start_date":" 06/29/2015","primary_txt":" Primary completion: 12/16/2019","primary_completion_date":" 12/16/2019","study_txt":" Completion: 12/16/2019","study_completion_date":" 12/16/2019","last_update_posted":"2020-01-18"},{"id":"81b63bf2-c9ae-44b6-a3b3-97a8d9e5ddd5","acronym":"","url":"https://clinicaltrials.gov/study/NCT02004106","created_at":"2021-01-18T09:09:08.457Z","updated_at":"2024-07-02T16:37:13.296Z","phase":"Phase 1","brief_title":"A Study to Evaluate Safety, Pharmacokinetics, and Efficacy of RO6895882 in Participants With Advanced and/or Metastatic Solid Tumors","source_id_and_acronym":"NCT02004106","lead_sponsor":"Hoffmann-La Roche","biomarkers":" CD8 • CEACAM5","pipe":" | ","alterations":" CEACAM5 expression","tags":["CD8 • CEACAM5"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CEACAM5 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cergutuzumab amunaleukin (RG7813)"],"overall_status":"Completed","enrollment":" Enrollment 110","initiation":"Initiation: 12/31/2013","start_date":" 12/31/2013","primary_txt":" Primary completion: 08/31/2016","primary_completion_date":" 08/31/2016","study_txt":" Completion: 08/31/2016","study_completion_date":" 08/31/2016","last_update_posted":"2018-03-06"}]